Phase I Study of the Anti-MUC-l Antibody, huHMFG1 (AS1402), in Patients with Advanced Breast Cancer

Saved in:
Bibliographic Details
Published in:Clinical immunology (Orlando, Fla.) Fla.), 2007-01, Vol.123, p.S110-S111
Main Authors: Courtenay-Luck, Nigel, Chief Scientific Officer, Antisoma Research Ltd, London, England, Pegram, Mark, Associate Professor of Medicine, David Geffen School of Medicine, Los Angeles, CA
Format: Article
Language:English
Subjects:
Allergy and Immunology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2007.03.494